Emergent BioSolutions Inc. (NYSE: EBS) has achieved a notable milestone with the U.S. Food and Drug Administration (FDA) approving the supplemental Biologics License Application (sBLA) for ACAM2000. The approval expands the vaccine’s indication to include the prevention of mpox, a development that comes at a critical juncture as mpox continues to spread globally, particularly across […]
Sequent Scientific Limited, a leading Indian pharmaceutical company, has achieved a significant milestone by securing prequalification (PQ) approval from the World Health Organization (WHO) for its Albendazole Active Pharmaceutical Ingredient (API). This achievement, made in collaboration with Mepro Pharmaceuticals Private Limited, marks a noteworthy advancement in the pharmaceutical sector and underscores the company’s commitment to […]
ICF (NASDAQ: ICFI), a global consulting and technology services provider, has been awarded a five-year, $236 million contract by the U.S. Agency for International Development (USAID) Bureau for Global Health. This recompete contract will enable ICF to continue delivering the Demographic and Health Surveys (DHS) Program, renowned globally as the “gold standard” of health surveys. […]
In an exciting development for migraine sufferers, Dr. Reddy’s Laboratories Ltd., a leader in the global pharmaceutical industry, has announced the launch of its groundbreaking, drug-free, non-invasive migraine management device, Nerivio, in Germany. This move, facilitated through its step-down subsidiary betapharm, signifies Dr. Reddy’s Laboratories’ foray into the realm of digital therapeutics in Europe, marking […]
lpca Laboratories Ltd. (lpca) has embarked on a collaboration with Omexa Formulary Pvt. Ltd. (Omexa), through a Technology Transfer Agreement aimed at fostering the development of an anti-cancer biosimilar for the global market. This strategic partnership grants Omexa non-exclusive rights to research, develop, manufacture, and market the biosimilar, marking a significant step in the fight […]
The World Health Organization (WHO) has announced a pivotal step in global health: the initiation of the world’s first malaria vaccine trials in Ghana, Kenya, and Malawi next year. This groundbreaking trial aims to combat one of the world’s most severe health challenges, particularly affecting young children at high risk of death. Pioneering Development in […]
Sanofi Pasteur, the French pharmaceutical giant, has announced the rollout of Dengvaxia, the world’s first dengue vaccine, in Guatemala in the upcoming days. This significant development was revealed at a news conference in Guatemala City, marking a crucial step in the fight against dengue fever, a mosquito-borne viral infection that poses severe global health challenges. […]
Amgen Inc., a leading American biopharmaceutical company, has achieved a significant milestone with the approval of its drug Parsabiv (etelcalcetide) by the European Commission (EC) for the treatment of secondary hyperparathyroidism (sHPT) in adult patients undergoing hemodialysis due to chronic renal disease. Breakthrough in sHPT Management sHPT is a complex and chronic condition that affects […]
Sun Pharma, an Indian multinational pharmaceutical company, has announced a collaboration with the International Centre for Genetic Engineering and Biotechnology (ICGEB) to develop a new dengue vaccine aimed at being safer, more effective, and more affordable than existing vaccines. This initiative marks the second collaboration between Sun Pharma and ICGEB, building on their earlier partnership […]